SciBase Expands to New Market in Pennsylvania and Receives First Order From Large Dermatology Practice
SciBase Expands to New Market in Pennsylvania and Receives First Order From Large Dermatology Practice
STOCKHOLM, Sept. 26, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), pioneering prevention and prediction in dermatology announces today a partnership with Seraly Dermatology in Pittsburgh, Pennsylvania. The strategic collaboration will allow SciBase to continue to broaden access of the Nevisense test to patients across the US, and further their commitment to the early detection of melanoma, when the disease is almost 100% curable. Seraly Dermatology will integrate several Nevisense systems into their skin cancer detection workflow.
2024年9月26日斯德哥爾摩 / PRNewswire / - SciBase控股公司（"SciBase"）（STO：SCIB），在皮膚科領域開拓了預防和預測，今天宣佈與賓夕法尼亞州匹茲堡的Seraly皮膚科學院合作。該戰略合作將使SciBase能夠繼續擴大Nevisense測試在美國各地患者中的使用，並進一步履行對黑色素瘤的早期檢測承諾，當疾病幾乎可以100%治癒時。Seraly 皮膚科將集成多個Nevisense系統到其皮膚癌症檢測工作流程中。
"Melanoma is the deadliest form of skin cancer and catching it early is key to survival. At Seraly Dermatology, we believe in providing our patients with the most advanced personalized care. For these reasons, we are keen to integrate the Nevisense test into our melanoma detection workflow. The Nevisense technology non-invasively analyzes the cellular structure of a patient's atypical moles right at point of care. This can help us not only personalize that patient's care but also improve clinical outcomes by practicing the earliest melanoma detection possible" says Mark Seraly, MD, Board-Certified Dermatologist, founder and CEO of Seraly Dermatology.
「黑色素瘤是皮膚癌中最致命的形式，早期發現對生存至關重要。在Seraly 皮膚科，我們堅信提供給我們的患者最先進的個性化護理。由於這些原因，我們急於將Nevisense測試整合到我們的黑色素瘤檢測工作流程中。Nevisense 技術可以在病人的非典型痣的細胞結構上非侵入性地分析，以幫助我們不僅個性化患者的護理，還可以通過儘早實踐最早期的黑色素瘤檢測來改善臨床結果」 Mark Seraly, MD，皮膚科醫生，Seraly 皮膚科創始人兼首席執行官說。
"We are thrilled to commence a partnership with Seraly Dermatology Their focus on individual patient care is one of many reasons we are proud to partner with them. I'm also pleased to see that our recent U.S. team expansion is already having a positive impact on the U.S. market by increasing access of the Nevisense test to more patients in new geographic areas", says Pia Renaudin, CEO of SciBase.
「我們很高興與Seraly 皮膚科建立合作關係。他們關注個體患者護理的特點是我們與他們合作的衆多原因之一。我也很高興看到我們最近的美國團隊擴張已經通過增加對Nevisense測試的使用覆蓋新的地理區域而對美國市場產生了積極影響」 Pia Renaudin，SciBase首席執行官說。
For additional information, please contact:
Pia Renaudin, CEO, tel. +46732069802, e-mail: [email protected]
欲了解更多信息，請聯繫:
Pia Renaudin，首席執行官，電話：+46732069802，電子郵件：[email protected]
Certified Advisor (CA):
認證顧問（CA）：
Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: [email protected]
Carnegie投資銀行股份公司（簡稱）
電話：+46（0）73 856 42 65
電郵：[email protected]
About SciBase
關於SciBase
SciBase is a global medical technology company, specializing on early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to enhance diagnostic accuracy, ensuring proactive skin health management.
SciBase是一家全球醫療科技公司，專注於皮膚病學早期檢測和預防。SciBase開發和推廣Nevisense，一個獨特的即時診斷平台，結合人工智能和先進的EIS技術，提升診斷準確性，確保積極的皮膚健康管理。
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
我們的承諾是儘量減少患者的痛苦，使臨床醫生通過及時檢測和干預來改善和挽救生命，降低醫療成本。
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
SciBase在瑞典斯德哥爾摩的卡羅林斯卡學院進行了20多年的研究，是皮膚病學進展的領先者。
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015 and the company's Certified Adviser is Carnegie Investment Bank AB (publ). Learn more at . For press releases and financial reportsvisit:
自2015年6月2日以來，該公司一直在納斯達克第一北增長市場交易所上市，公司的認證顧問是Carnegie Investment Bank Ab（publ）。了解更多信息，請訪問。有關新聞發佈和財務報告，請訪問：
This information was brought to you by Cision
本信息由Cision提供
The following files are available for download:
以下文件可供下載：
|
PR Seraly eng final |
|
|
Press Release Seraly |
|
PR Seraly eng final |
|
|
Press Release Seraly |
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎？
譯文內容由第三人軟體翻譯。